San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Drug Uses Trick Play In Weight-Loss Game

BIOTECH: S.D. Has Novel Therapies for Fat Fight

Maybe it’s the beaches, bikinis and sunshine. Maybe it’s the local talent pool.

Obalon Announces Completion of $30 Million in Financing

San Diego-based Obalon Therapeutics Inc., a private medical technology company, announced the completion of $30 million in financing to advance the development of their weight-loss device.

TruMed Systems Moves From EvoNexus to Irvine Co. Space

TruMed Systems Inc., a medical device company, graduated from the San Diego-based incubator EvoNexus with a $5.5 million Series B funding round, according to a recent press release.

Adamis Pharmaceuticals Reports Raising $10.6 Million in Public Offering

Adamis Pharmaceuticals Corp., a San Diego-based biopharmaceutical company, raised about $10.6 million in a previously announced public offering, according to a recent company press release.

Ligand Pharmaceuticals Partner's Drug Receives Orphan Designation

San Diego-based Ligand Pharmaceuticals Inc. announced that its partner New York-based Retrophin Inc. has received orphan drug designation from the U.S. Food and Drug Administration for Sparsentan, a drug developed to treat scar tissue in the filtering unit of the kidney.

Trovagene Inc. Announces Collaboration With UCSD Moores Cancer Center

Trovagene Inc., a San Diego molecular diagnostics company, announced that it has entered into a clinical collaboration with the University of California, San Diego's Moores Cancer Center.

Tease photo

Arcturus Partners With Canadian Company for Manufacture of RNA Medicines

San Diego-based Arcturus Therapeutics and Canadian company Precision NanoSystems announced a partnership for the manufacture of RNA medicines.

Tease photo

AMN Announces Completion of Acquisitions From OGH

San Diego-based AMN Healthcare Services Inc., a health care staffing company, announced the completion of the previously announced acquisition of Onward Healthcare, Locum Leaders and Medefis from OGH LLC for a total purchase price of $82.5 million.

ACA Means Business in 2015; Other New Laws Bring Changes

The California Legislature had an active year, adding 930 new laws that will come into effect in 2015 – many of which aim to reform the state’s health care industry. These come as the federal health care reform hits businesses in a big way this year.

Aethlon Device Approved For Treating Patients

BIOTECH: Firm’s Hemopurifier Makes A Top Invention List

San Diego-based Aethlon Medical Inc., a medical device company developing therapies for infectious diseases and cancer, announced that the U.S. Food and Drug Administration has approved a clinical protocol to treat Ebola-infected individuals in the U.S. with the Aethlon Hemopurifier.

Tease photo

Health Tracking Goes Deep With This New Device

BIOTECH: Markers Are Measured on Molecular Level

Notable investors, and even a Hollywood star, are betting millions on the Cue, a diagnostic device and consumer health product that may one day be as ubiquitous as the household thermometer.

Trovagene Announces Clinical Collaboration With City of Hope

Trovagene Inc., a San Diego molecular diagnostics company, announced that it has entered into a clinical collaboration with Los Angeles-based City of Hope, a research and treatment center for cancer, diabetes and other life-threatening diseases

Ansun Biopharma to Pay $2 Million to Settle Fraud Complaints

San Diego-based Ansun Biopharma Inc. will pay about $2 million to settle civil and criminal complaints about submitting false and fraudulent claims on grants and a contract with the National Institutes of Health (NIH).

Suneva Wins FDA Approval for Acne Scar Treatment

Suneva Medical Inc., a San Diego-based aesthetics company, announced that the U.S. Food and Drug Administration (FDA) has approved its dermal filler, Bellafill, for the treatment of acne scars.

Isis Pharmaceuticals, Johnson & Johnson Sign $835 Million Deal

Johnson & Johnson has signed an $835 million pact with Carlsbad-based Isis Pharmaceuticals Inc., joining a growing list of big companies allied with the local company’s research and development group.